Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
Clinical trial NCT04060147 · TERMINATED
Trial details
- NCT number
- NCT04060147
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2021-09-02
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.